All Optofluidic Application Notes
- Opto® Memory B Discovery Human Workflow
- Empowering Rapid and Robust Antibody Response: The Role of Next-Generation Antibody Discovery in Preparedness for Emerging Diseases and Endemic Threats
- Integrated Biomarker Discovery and T Cell Analysis using the IsoSpark™ and Beacon® Platforms
- Discover Lead Molecules Against Difficult Targets in 1 Week with Opto® Plasma B Discovery 4.0
- Identify and Select Optimal CAR T Cell Phenotypes with the Opto™ Cell Therapy Development Workflow
- Multidimensional Analysis of T Cell Cytotoxicity and Serial Killing Using the Opto™ Cell Therapy Development Workflow
- Rapid Discovery of Therapeutic Antibodies for the SARS-CoV-2 Pandemic Virus Using the Opto™ Viral Neutralization 1.0 Workflow
- Rapidly Discover and Select Potent Ligand/ Receptor Blocking Antibody Lead Candidates with Opto™ Plasma B Discovery
- Rapid Selection of Antibodies Against Membrane Targets using Cell-Binding Assays and the Opto™ Plasma B Discovery Workflow
- Bring Product Quality Assessment into Early Clone Selection with the Opto™ Assure Aggregation Assay
- Identify Top Producing Clones with Favourable Product Quality Attributes
- Rapid Single-Cell Cloning and Screening to Identify Superior Reporter Cell Lines Using the Lightning™ Optofluidic System
- Accessing Greater Antibody Sequence Diversity
- Rapid High-Resolution Screening of Plasma B Cells to Identify Antibody Lead Candidates
- Unravel the Complexity of Single Natural Killer Cell Cytotoxicity and ADCC Mediation
- Directly Link T Cell Phenotype and Function to Genotype with the Opto™ Cell Therapy Development 1.0 Workflow
- Profile and Recover Polyfunctional T Cells Using Multiplexed Cytokine Secretion Assays
- Abveris on Antibody Discovery
- FDA-Accepted Monoclonality Assurance on the Beacon® Optofluidic System for Cell Line Development
- Perform Multi-omic Analysis to Directly Link T Cell Polyfunctionality to Gene Expression
- Discover Lead Molecules Against Difficult Membrane Targets Inaccessible by Hybridoma Methods
All Proteomic Barcoding Application Notes
- Integrated Biomarker Discovery and T Cell Analysis using the IsoSpark™ and Beacon® Platforms
- Characterizing Adoptive Cell Therapies using Bruker's Proteomic Barcode Technology
- Proteomic Product Suite for NK Cells
- Applying Single-Cell Proteomics to Explore Immune Responses in Organ Transplantation
- Key Functional Insights Uncovered with CodePlex High-Plex Low Volume Immunoassays
- Proteomic Product Suite for Autoimmune Inflammation
- Proteomic Product Suite for Tumor Resistance
- Proteomic Product Suite for Oncology & Tumor Functional Phenotyping
- Proteomic Product Suite for Cancer Immunology
- Proteomic Product Suite for CAR-T Therapy
- Proteomic Product Suite for Neuroinflammation
- Proteomic Product Suite for Cellular and Regenerative Medicine
- Proteomic Product Suite for Infectious Disease
- Reveal Sources of Immune Modulation with the Single-Cell Innate Immune Solution
- Assessing Functional Quality of Single TILs for Correlative Immunotherapy Biomarkers
- PSI™ Enables Cell Engineering and Therapy from Discovery to Predicting Outcome
